bladder cancer
Showing NaN - NaN of 49
Bladder Cancer, Patient Engagement, Patient Empowerment Trial in Manhasset, Philadelphia (Cancer Resource Information Support
Recruiting
- Bladder Cancer
- +3 more
- Cancer Resource Information Support (CRIS)
- Usual Care Enhanced
-
Manhasset, New York
- +1 more
Feb 2, 2023
Primary and Metastatic Tumors in Renal Cell Carcinoma and
Recruiting
- Renal Cell Carcinoma
- +4 more
- Immune checkpoint inhibitor targeting PD1
-
Philadelphia, PennsylvaniaFox Chase Cancer Center - Philadelphia
Jan 27, 2023
Urothelial Carcinoma, Bladder Cancer Trial in United States (drug, radiation, biological)
Recruiting
- Urothelial Carcinoma
- Bladder Cancer
- Durvalumab (Cohort 1-3)
- +7 more
-
Phoenix, Arizona
- +10 more
Jan 11, 2023
Bladder Cancer Trial in Worldwide (Atezolizumab)
Active, not recruiting
- Bladder Cancer
-
Birmingham, Alabama
- +76 more
Dec 6, 2022
Bladder Cancer Trial in Worldwide (Atezolizumab)
Active, not recruiting
- Bladder Cancer
-
Birmingham, Alabama
- +76 more
Dec 6, 2022
Intravesical Therapy and Surgery as Treatment Options for
Recruiting
- Bladder Cancer
- +2 more
-
Birmingham, Alabama
- +37 more
Nov 28, 2022
Bladder Cancer Trial in Philadelphia (social incentive-based gamification)
Completed
- Bladder Cancer
- social incentive-based gamification
-
Philadelphia, Pennsylvania
- +1 more
Nov 8, 2022
Urothelial Carcinoma, Bladder Cancer Trial in United States (Placebo, Pembrolizumab)
Completed
- Urothelial Carcinoma
- Bladder Cancer
- Placebo
- Pembrolizumab
-
Phoenix, Arizona
- +27 more
Sep 16, 2022
Arquer's MCM5 Elisa Test to Aid in Monitoring of Recurrence in
Recruiting
- Bladder Cancer
- ADXBLADDER
-
Denver, Colorado
- +12 more
Aug 18, 2022
Bladder Cancer, Urothelial Carcinoma Trial in United States (OGX-427, Docetaxel)
Completed
- Bladder Cancer
- Urothelial Carcinoma
-
Birmingham, Alabama
- +34 more
Jul 7, 2022
Bladder Cancer Trial in United States (cisplatin, 5-fluorouracil, Mitomycin)
Urothelial Carcinoma, Bladder Cancer, Urethral Cancer Trial in United States (Biospecimen Collection)
Active, not recruiting
- Urothelial Carcinoma
- +3 more
- Biospecimen Collection
-
Los Angeles, California
- +7 more
Feb 14, 2022
Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)
Completed
- Prostate Cancer
- +6 more
- MGA271
-
Los Angeles, California
- +11 more
Feb 4, 2022
Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)
Terminated
- Mesothelioma
- +12 more
- MGD009
-
Los Angeles, California
- +19 more
Feb 4, 2022
Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)
Recruiting
- Urothelial Carcinoma
- +20 more
- IK-175
- IK-175 and nivolumab
-
Gilbert, Arizona
- +9 more
Feb 3, 2022
HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)
Recruiting
- HER2-positive
- +30 more
- CT-0508
-
Duarte, California
- +4 more
Feb 1, 2022